The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer patients in India a much needed and timely therapy option, he added.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fHWiX7
via IFTTT
0 comments:
Post a Comment